Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi MSCI Europe Screened UCITS ETF Acc

EUSC · LU3086388124 · class UCITS ETF Acc · EUR · domicile Luxembourg
Equity · Europe · Energy · Sustainable / ESGSFDR art. 8
Index tracked: MSCI Europe Screened Select ex Thermal Coal Net EUR Index
TER
0.12%+ trans. 0.20%
Fund size
641 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 9 Sept 2025 · costs from the KID as of 2 Sept 2026 · 366 securities held · 1 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The Sub-Fund is a financial product that promotes among other characteristics environmental and/or social characteristics characteristics pursuant to Article 8 of the Disclosure Regulation, as further described in Annex 1 - ESG Related Disclosures to this Prospectus, replicating an Index integrating an environmental, social and governance (ESG) rating. The objective of this Sub-Fund is to track the performance of the MSCI Europe Screened Select ex Thermal Coal Index (the "Index") and to minimize the tracking error…

Performance since series start (in euro) — base 100

9 Sept 20258 Sept 2026 · dividends reinvested where declared by the issuer
2026122100119
High 122 (10 Aug 2026) · low 100 (16 Sept 2025) · last 119. Past performance is not indicative of future results.

Returns in euro

1 year+19.4%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+19.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.62%12.62%
Max drawdown−9.74%−9.74%
Sharpe1.281.28
Sortino1.991.99
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · EUSC · LU30863881241
RebalixEUSC · LU3086388124 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: index series not published by the issuer

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 366 securities · top-10 weight = 23.1%
Top holdingsWeight
ASML HOLDING NV5.2%
HSBC HOLDINGS PLC2.9%
ROCHE HOLDING AG - GENUSSS CHF2.4%
NOVARTIS AG-REG2.4%
ASTRAZENECA GBP2.0%
SIEMENS AG-REG1.9%
SAP SE / XETRA1.7%
BANCO SANTANDER SA MADRID1.7%
ALLIANZ SE-REG1.6%
SCHNEIDER ELECT SE1.5%
Countries (% of fund)
United Kingdom19.3%France16.7%Switzerland13.5%Germany13.1%Netherlands10.0%
Sectors (% of fund)
Financials28.9%Industrials20.0%Health Care14.4%Information Technology10.2%Consumer Discretionary5.6%

Listing venues

ESMA register (FIRDS) and official exchange lists
EUSC · Euronext Paris
+ 15 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/LU3086388124/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/LU3086388124/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/LU3086388124/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/LU3086388124
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · EUSC · LU30863881242